Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
52 Bailey Drive
Washington Crossing, PA 18977Phone+1 908-927-9600
Summary
- Entrepreneurial physician-scientist with substantial industry experience sourcing and developing drugs and preparing them for marketing. In addition to senior roles for pharmaceutical companies of varying size, I've held leadership positions and started companies in related sub-industries (professional investment research/clinical research informatics/strategic management consulting), resulting in broad clinical and strategic business development experience and domain expertise.
Most recently, I have joined a small, rapidly growing pharmaceutical development company, Strongbridge, which is dedicated to identifying, developing, an bringing drugs to patients who suffer from orphan diseases with an initial focus on orphan endocrine diseases.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1990 - 1993
Pennsylvania State University College of MedicineClass of 1990
Certifications & Licensure
PA State Medical License 2000 - 2016
Clinical Trials
- Treatment for Endogenous Cushing's Syndrome Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 16 citationsLevoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study.Rosario Pivonello, Atanaska Elenkova, Maria Fleseriu, Richard A Feelders, Przemysław Witek
Frontiers in Endocrinology. 2021-04-07 - 15 citationsLevoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndromeEliza B Geer, Roberto Salvatori, Atanaska Elenkova, Maria Fleseriu, Rosario Pivonello
Pituitary. 2021-02-01 - 2 citationsCorrection to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.Eliza B Geer, Roberto Salvatori, Atanaska Elenkova, Maria Fleseriu, Rosario Pivonello
Pituitary. 2021-02-01
Professional Memberships
- Member
Industry Relationships
- Vice President, Clinical Research and Development, Strongbridge Biopharma2015 - Present
External Links
- Websitehttp://www.strongbridgebio.com
- LinkedInhttps://www.linkedin.com/in/pharmagrowth
- Research Gatehttps://www.researchgate.net/profile/Fj_Cohen
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
